Mayne Pharma Group Ltd
ASX:MYX
Mayne Pharma Group Ltd
ASX:MYX
Price:
7.01 AUD
-1.54%
Market Closed
Updated:
May 10, 2024
Mayne Pharma Group Ltd
Non-Reccuring Items
|
Mayne Pharma Group Ltd
Non-Reccuring Items Peer Comparison
Comparables:
RCE
NEU
BOT
PBP
C
CU6
Competitive Non-Reccuring Items Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Non-Reccuring Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Mayne Pharma Group Ltd
ASX:MYX
|
Non-Reccuring Items
-AU$85m
|
CAGR 3-Years
8%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
Recce Pharmaceuticals Ltd
ASX:RCE
|
Non-Reccuring Items
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
Non-Reccuring Items
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Botanix Pharmaceuticals Ltd
ASX:BOT
|
Non-Reccuring Items
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Probiotec Ltd
ASX:PBP
|
Non-Reccuring Items
-AU$1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
Non-Reccuring Items
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Mayne Pharma Group Ltd's Non-Reccuring Items?
Non-Reccuring Items
-85m
AUD
-85m
AUD
Based on the financial report for Jun 30, 2023, Mayne Pharma Group Ltd's Non-Reccuring Items amounts to -85m AUD.
What is Mayne Pharma Group Ltd's Non-Reccuring Items growth rate?
Non-Reccuring Items CAGR 5Y
17%
17%
Over the last year, the Non-Reccuring Items growth was -5%. The average annual Non-Reccuring Items growth rates for Mayne Pharma Group Ltd have been 8% over the past three years , 17% over the past five years .
You don't have any saved screeners yet
